Please login first

4th International Electronic Conference on Medicinal Chemistry

1–30 Nov 2018
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us Become a Sponsor

Welcome from the Chair

For the fourth year in a row, the International Electronic Conference on Medicinal Chemistry will be organized and sponsored by the peer-reviewed journal Pharmaceuticals, which is edited by MDPI. The conference will be held online at during the month of November 2018.

The aim of the Conference is to gather researchers from all over the world and encourage discussions on any scientific field related to drug discovery and development. Posting presentations, videos, or posters disclosing your recent outstanding results enables you to take advantage of the conference to promote your work among thousands of your peers. Participation, as an author or a visitor, is ABSOLUTELY FREE; simply register on the home page.

This year, as the conference sponsor, Pharmaceuticals will be giving an award for the Best Presentation as elected by the scientific committee, which consists of 500 Swiss Francs. We hope you will be able to join this exciting event and enjoy a stimulating exchange with your peers around the world. Also, we will launch a Special Issue covering the event.

On behalf of our dynamic editorial staff and active scientific committee, we warmly invite you to join us during this fourth edition and we look forward to posting your contributions.

Conference Chair

Dr. Jean Jacques Vanden Eynde
Editor-in-Chief of Pharmaceuticals, Former Head of the Department of Organic Chemistry, University of Mons-UMONS, Belgium

Keynote Speakers

Laboratory of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy of University of Porto, Portugal

Small molecules from the sea: models for innovative antimicrobial agents
Research Keywords
medicinal chemistry; organic synthesis; heterocycles, P-glycoprotein; anticancer; anticoagulants; chiral drugs; marine natural products

Institut für Biochemie, Department für Chemie, Universität zu Köln, Zülpicher Straße 47, D-50674 Köln, Germany

Dr. Karsten Niefind is biochemist and apl. Professor at the Institute of Biochemistry of the University of Cologne. His research and teaching activities are dedicated to basic biochemistry and to the structure/function relationships of selected proteins, in particular involved in signal transduction and (plant) innate immune response or relevant for biotechnological applications.
Research Keywords
structural biology; protein crystallography; enzymology; protein-protein interactions; protein kinases; EDS1-family of plant innate immune response proteins; human leukocyte elastase

Senior research fellow of the Latvian Institute of Organic Synthesis, Deputy Chairman, Division of Chemical, Biological and Medical Sciences, Latvian Academy of Sciences, Aizkraukles 21, Rīga, LV 1006, Latvia

Gunars Duburs Professor, Dr.chem.habil, Full Member of the Latvian Academy of sciences. Principal scientist, Latvian Institute of Organic Synthesis, Laboratory of Membrane active compounds and beta-diketones. Areas of activities: organic chemistry, medicinal chemistry. Scientific interests: chemistry of heterocyclic compounds, azines, membrane active compounds. Discovered and elaborated novel drugs: radioprotector diethone for oncological clinics, antihypertensive and antianginal drug riodipine (foridone), as well antioxidant diludine as carotene stabiliser and stimulant of productivity of animals. Publications: 550 scientific articles, 475 thesis, 75 patents.
Research Keywords
heterocyclic chemistry (mainly partially hydrogenated azines: dihydro- (tetrahydro-) pyridines, pyrimidines, polycyclic derivatives) - studies of chemical, physical chemical and biological properties; medicinal chemistry (synthesis and studies of neurotro

Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences Via Ospedale 72, I-09124 Cagliari, Italy

Research Keywords
medicinal chemistry; enzyme inhibitors; heterocyclic compounds, antiproliferative agents

Department of Oral Biology, University of Florida College of Dentistry, Gainesville, FL 32610, USA

Research Keywords
host fungus interactions, antimicrobial peptides, antifungal peptides, defensins, cathelicidins

Department of Pathology & Microbiology University of Nebraska Medical Center, USA

Dr. Guangshun Wang is an Associate Professor at the University of Nebraska Medical Center (Omaha, Nebraska, USA). He is interested in developing novel compounds to treat human diseases, such as drug-resistant superbugs, viruses and cancer. His laboratory utilizes an integrated approach by combining chemistry, biophysics, bioinformatics, genetics, and structural biology. Two general methods are exploited to identify novel drug candidates. First, library screen is used. To search and screen starting templates, his laboratory has constructed the Antimicrobial Peptide Database (, which is widely utilized. As of July 2018, this database contained 2987 antibacterial, antiviral, antifungal, anti-parasitic and anticancer peptides, primarily from natural sources, covering the six life kingdoms (bacteria, archaea, fungi, protists, plants, and animals). Second, structure-based design is conducted. The lab uses multidimensional nuclear magnetic resonance (NMR) spectroscopy to determine the 3D structure of important pepti

Department of Molecular Biology, Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), PTS Granada, Av del Conocimiento 17, 18016 Granada, Spain

Dr. Alfredo Berzal-Herranz, Biologist. Senior Researcher at the Instituto de Parasitología y Biomedicina López-Neyra” belonging to the Spanish National Research Council (IPBLN-CSIC), Granada, Spain. In April 1990 obtained his Ph.D in Biochemistry and Molecular Biology from the Autónoma University of Madrid, Spain. After a short postdoctoral term at the BMC-Uppsala University (Sweden), he moved to the University of Vermont (USA; Dr. John Burke’s laboratory), where he was involved in the biochemical characterization of ribozymes. Since December 1993 he leads his own research group at the IPBLN-CSIC. He is the author of more than 80 scientific publications. His current scientific interest is the study of the biological activity of the RNA, mainly focusing in the structure/function of conserved functional RNA domains in viral RNA genomes (mainly HIV and HCV and flavivirus), and its potential as antiviral targets; design and characterization of RNA molecules with inhibitory activity (e.g. ribozymes, aptamers, antisense RNAs) a

School of Environmental Science and Engineering, Kochi University of Technology, Tosayamada, Kami, Kochi 782-8502, Japan

My name is Le Thi Song. My scientific research began in the area of Electrochemical and Corrosion Protection during my undergraduate studies at Department of Chemistry at Hanoi University of Science and Technology, Vietnam in 2009. From 2010 to 2012, I worked as master researcher at Interfacial Engineering Lab, Chemical and Biochemical Engineering Department at Dongguk University, Seoul, South Korea. Then in 2013, I became a Ph.D researcher at Kochi University of Technology, Japan under supervision of professor Nagatoshi Nishiwaki and received my Ph.D in organic synthesis in 2015. Then, I worked as a visiting researcher at this university for 1 year. From 2016, I became a research collaborator at Ton Duc Thang University in Vietnam. My research interests comprise not only synthetic organic chemistry using nitro compounds, heterocycles (ring transformation, dinitropyridone, nitroanilines, nitropyridines …), but also superhyrophobic coating, silica thin film, electroplating, corrosion and so on.

Foodborne Toxin Detection and Prevention Research Unit, Western Regional Research Center, US Department of Agriculture, Albany, California, USA.

Jong H. Kim is a Research Scientist in the Foodborne Toxin Detection and Prevention Research Unit, Western Regional Research Center, US Department of Agriculture, Albany, California, USA. His research focuses on the development of intervention strategies for control of fungal pathogens including mycotoxigenic fungi. He provides chemo-biological expertise, particularly in the identification of cellular targets, mechanisms of action and compound interaction, and participates in resistance management in collaboration with industry and academia.
Research Keywords
antifungal; antioxidant system; cell wall integrity; chemosensitization; drug repurposing; drug resistance; filamentous fungi; mitochondrial respiration; mycotoxins; oxidative stress; redox-active; signaling pathway; small molecules; synergism; yeast path

Pharmacelera, Plaça Pau Vila, 1, Sector 1, Edificio Palau de Mar, Barcelona 08039, Spain

Dr. Alessandro Deplano is Pharmacelera’s Medicinal/Computational Chemist. He has got a Ph.D. in Medicinal Chemistry at the University of Cagliari, Italy, with a thesis entitled “Design, synthesis and SAR of small molecules acting on pain pathways” under the supervision of Prof. Valentina Onnis. His Ph.D. studies were focused on the design and synthesis of numerous molecules with different structure and specific pharmacological targets, in particular compounds endowed with analgesic activities. He worked also on synthesis of new molecules endowed with carbonic anhydrase inhibitory activity, antiproliferative activities on human cancer cell lines, and molecules endowed with nematicidal activity. He holds a Master degree in Pharmaceutical Chemistry and Technology, at University of Cagliari, which give him a strong background in pharmacology, biology and anatomy, along with organic and medicinal chemistry, field in which he gave his thesis dissertation. During his Ph.D. program he spent a semester at American University of Washington

Keynote Presentations

List of accepted submissions (75)

Id Title Authors Presentation Video Poster PDF
sciforum-021513 Impact of different geometrical structures of copper(II) complexes on interactions with bio-relevant nucleophiles under physiological conditions , , , N/A Poster PDF Show Abstract
sciforum-020865 Synthesis and Evaluation of New 6-formyl-oxazolo[3,2-a]pyrimidine derivatives as Potential Src Kinase Inhibitors , , , , , N/A Poster PDF Show Abstract
sciforum-020857 The effects of polar and non polar compounds from endophytic actinomycetes in Ocmium tenuiflorum (Tulsi) and Azadirachta indica (Neem) on veterinary and human pathogens , , , , N/A Poster PDF Show Abstract
sciforum-022553 New prenylchalcones targeting the MDM2-p53 protein-protein interaction: synthesis and evaluation of antitumor activity , , , , , , , , N/A Poster PDF Show Abstract
sciforum-022520 Antiproliferative activity of steroidal oxime and its O-alkylated derivatives , , , , N/A Poster PDF Show Abstract

Event Awards

Best Presentation Award
The Awards
Best Presentation Award

Number of Awards Available: 1

This year, as a sponsor, Pharmaceuticals would like to award the best presentation as elected by the members of the scientific committee. The Award will consist of 500 Swiss Francs. We look forward to posting your contributions.
Terms and Conditions:
  1. Full PPT presentation must be submitted to ECMC-4.
  2. The quality of the presentation.
  3. The scientific content of the presentation


  1. Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above.
  2. Total score for each presentation will be ranked, from highest to lowest.
  3. If two or more students get the same score, further evaluation will be carried out.
  4. All decisions made by the Evaluation Committee are final.

Best Presentation at ECMC-4

Pharmaceuticals and the Organizing Committee of ECMC-4 congratulate Valentina Barcherini, Margarida Espadinha, Joana Soares, Sara Gomes, Alexandra Antunes, Lucília Saraiva, Maria Santos who received an award for the best presentation at ECMC-4:

Topic: Enantiopure oxazoloisoindolinones: Promising small molecules for p53-based therapy with potential anticancer properties
authored by Valentina Barcherini, Margarida Espadinha, Joana Soares, Sara Gomes, Alexandra Antunes, Lucília Saraiva, Maria Santos

"Valentina Barcherini is a second-year PhD student at M.M.M. Santos’ team (Faculty of Pharmacy, University of Lisbon) and member of the Medicinal Chemistry group of the Research Institute for Medicines, iMed.ULisboa. Valentina’s doctoral research is centred on the development of novel small molecules that act as dual p53-MDM2/X protein-protein interactions inhibitors. Valentina holds a master’s degree in Bioorganic Chemistry from the New University of Lisbon, Portugal. Previously, she graduated in Applied Chemistry in University of Padova (Italy)."

Conference Chairs

Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium


Conference Committee

Formerly professor at the Haute Ecole Provinciale de Hainaut-Condorcet, 7330 Saint-Ghislain, Belgium

Università degli Studi di Cagliari, Dipartimento di Scienze Chimiche e Geologiche, Cittadella Universitaria, SS 554, bivio per Sestu, 09042, Monserrato (CA), Italy

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA

Faculté de Pharmacie, Université Libre de Bruxelles, Campus Plaine CP 205/5, 1050 Brussels, Belgium

PharmaCampus Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität, Corrensstr. 48, 48149, Muenster, Germany

Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências, Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal

School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152−160 Pearse Street, Dublin 2 D02 R590, Ireland

Universidade Federal do Rio de Janeiro, IPPN, CCS, Bloco H - Ilha do Fundão, Rio de Janeiro, RJ - 21941-902, Brazil

School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, Norfolk NR4 7TJ, UK

Normandie Univ, Univ Rouen; INSA Rouen, CNRS, Laboratoire COBRA UMR6014, Bâtiment IRCOF, 1 rue Tesnière, F-76821 Mont Saint-Aignan Cedex, France

Call for Papers

The members of the scientific committee are pleased to announce the Call for Papers for the 4th International Electronic Conference on Medicinal Chemistry and to invite each researcher working in that exciting field of science to share his/her recent results with his/her colleagues around the world.

The conference will cover a wide range of aspects involved in drug discovery and development. A non exhaustive list of topics that will be considered comprises:

  • Animal experimentation
  • Assay development
  • Biomarkers
  • Biomolecules
  • Biosensors
  • Biotechnology
  • Chemical synthesis
  • Clinical studies and side effects reports
  • Combinatorial chemistry
  • Drug delivery (including bioconjugates and prodrugs)
  • High throughput screening
  • Hit identification
  • Imaging techniques
  • In silico experiments
  • In vitro studies
  • Lead optimization
  • Omics
  • Pharmaceutical analysis
  • Scale-up
  • Structure–activity relationships
  • Target selection

Participation at the 4th International Electronic Conference on Medicinal Chemistry is absolutely free of charge for contributors and visitors. Researchers are invited to provide a short abstract on line at from now until October 25, 2018. Acceptance will be notified within a week after submission of the abstract. Then the author(s) will be asked to present their work (in English) in the form of a slide show (or a video) using the template provided by the conference (see Instructions for Authors). Posters, realized following the template provided online, will also be considered. All accepted submissions will be displayed online, at, on November 1-30, 2018.

Authors of the most outstanding contributions, as selected by the Scientific Committee, will be invited to publish their work as a research article free of charge or at a discounted price, in a Special Issue of the journal Pharmaceuticals.

The Scientific Committee looks forward to receiving contributions in response to this call and will be glad to provide any further information to interested parties. Questions may be addressed to the chairman via e-mail at or to the Pharmaceuticals editorial office at

We thank you in advance for your attendance of this conference and look forward to a stimulating exchange.

Instructions for Authors

Instructions for Authors

Submissions should be done by the authors online by registering with, and using the "Start New Submission" function once logged into system.

Researchers interested in attending the conference must submit, on this website and not later than 25 October 2018, an abstract of the work they intend to present.

After the abstract is accepted by the Scientific Committee (1-5 days after receipt of the abstract), the authors will be invited to prepare a full description of their work preferably under the form of a PowerPoint presentation, and to upload it before 30 October 2018 to ensure final check.

The presentations will be accessible on during the time of the conference.

Authors are encouraged to prepare a presentation using the template provided by the Conference. Slides will be displayed directly in the website using's proprietary slides viewer. They can be prepared in exactly the same way as for any traditional conference where research results can be presented. Slides should be converted to the PDF format before submission so that our process can easily and automatically convert them for online displaying.

Electronic Conference on Medicinal Chemistry PPT template file

Electronic Conference on Medicinal Chemistry Poster template file

The following organization is recommended for your presentation:

  • Length of the presentation: no more than 30 slides
  • Slide 1 (strictly one slide): Title, Authors’ names, Affiliation(s), email address of the corresponding Author, and, not mandatory, logos of the laboratory and/or institution;
  • Slide 2 (strictly one slide): Graphical Abstract, repeat the title of the presentation but avoid other text as far as possible;
  • Slide 3 (strictly one slide): Abstract (max 200 words) and 3-5 keywords separated by semicolons;
  • Slide 4 and following slides: should contain (in the given sequence) Introduction, Results and Discussion; Conclusions.
  • Last slide: Acknowledgments and, not mandatory, logos of sponsors of the work.


MDPI, the publisher of the platform, is an open access publisher. We believe that authors should retain the copyright to their research works. Hence, by submitting a contribution to this conference, the authors retain the copyright of their contribution, but they grant MDPI AG the non-exclusive right to publish this contribution online on the platform. This means the authors can easily submit their contribution to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).

Conference Organizers

Dr. Shu-Kun Lin, MDPI, Basel, Switzerland
Dr. Franck Vazquez, MDPI, Basel, Switzerland
Ms Changzhen Fu, MDPI Branch Office, Wuhan, China
Ms Silver Huang, MDPI Branch Office, Wuhan, China
Ms Verna Zheng, MDPI Branch Office, Wuhan, China


MDPI, the publisher of the platform, is an open access publisher. We believe that authors should retain the copyright to their research works. Hence, by submitting a contribution to this conference, the authors retain the copyright of their contribution, but they grant MDPI AG the non-exclusive right to publish this contribution online on the platform. This means the authors can easily submit their contribution to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).

Sponsors and Partners

For information regarding sponsorship and exhibition opportunities, please click here.



Exhibition Hall